SCHEMBL5113415

SCHEMBL5113415

O=C(c1ccc2ccccc2n1)N1CCN(CCc2ccc(F)cc2)CC1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRIN2B Q13224 2/20 0.59
PRKAA2 P54646 1/20 0.59
MEN1 O00255 2/20 0.57
KMT2A Q03164 2/20 0.57
TSHR P16473 1/20 0.55
GAA P10253 2/20 0.52
MAPK1 P28482 1/20 0.52
RAB9A P51151 1/20 0.52
SMN1; SMN2 Q16637 1/20 0.52
ALDH1A1 P00352 1/20 0.52
HTR2A P28223 3/20 0.52
HTR2C P28335 2/20 0.52
FAAH O00519 1/20 0.52
MAPT P10636 1/20 0.51
KCNH2 Q12809 1/20 0.50
PARP1 P09874 1/20 0.49
DPP4 P27487 1/20 0.48
DPP9 Q86TI2 1/20 0.48
DRD4 P21917 1/20 0.48
SLC6A2 P23975 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13149912 0.84 GRIN2B (0.68) GRIN2BMEN1KMT2ATSHRGAA
SCHEMBL517941 0.81 PRKAA2 (0.73) PRKAA2MEN1KMT2AFAAHKCNH2
SCHEMBL5106532 0.81 PRKAA2 (0.64) PRKAA2MEN1KMT2AHTR2AHTR2C
SCHEMBL13149900 0.79 GRIN2B (0.53) GRIN2BMEN1KMT2ATSHRGAA
Hydrochloric Acid SCHEMBL6584348 0.77 GRIN2B (0.88) GRIN2BPRKAA2MEN1KMT2ATSHR
SCHEMBL1134958 0.77 GRIN2B (0.75) GRIN2BPRKAA2MEN1KMT2ATSHR
SCHEMBL15302865 0.77 PRKAA2 (0.63) GRIN2BPRKAA2MEN1KMT2AHTR2A
SCHEMBL9513154 0.76 MEN1 (0.68) PRKAA2MEN1KMT2AHTR2AHTR2C
SCHEMBL2228011 0.76 GAA (0.66) MEN1KMT2ATSHRGAAMAPK1
SCHEMBL5099895 0.76 HTR2A (0.55) PRKAA2MEN1KMT2AHTR2AHTR2C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7329749-B2 Piperazinylcarbonylquinolines and -isoquinolines MERCK PATENT GESELLSCHAFT (DE) 2008-02-12 US claimed
WO-2002057256-A9 PIPERAZINYLCARBONYLQUINOLINES AND -ISOQUINOLINES MERCK PATENT GMBH (DE) 2005-12-08 WO claimed
EP-1366039-B1 PIPERAZINYLCARBONYLQUINOLINES AND -ISOQUINOLINES MERCK PATENT GMBH (DE) 2005-09-07 EP claimed
US-20040077657-A1 Piperazinylcarbonylquinolines and -isoquinolines MERCK PATENT GMBH (DE) 2004-04-22 US claimed
EP-1366039-A1 PIPERAZINYLCARBONYLQUINOLINES AND -ISOQUINOLINES MERCK PATENT GmbH (DE) 2003-12-03 EP claimed
WO-2002057256-A1 PIPERAZINYLCARBONYLQUINOLINES AND -ISOQUINOLINES MERCK PATENT GMBH (DE) 2002-07-25 WO claimed
US-7329749-B2 Piperazinylcarbonylquinolines and -isoquinolines MERCK PATENT GESELLSCHAFT (DE) 2008-02-12 US disclosed
WO-2002057256-A9 PIPERAZINYLCARBONYLQUINOLINES AND -ISOQUINOLINES MERCK PATENT GMBH (DE) 2005-12-08 WO disclosed
EP-1366039-B1 PIPERAZINYLCARBONYLQUINOLINES AND -ISOQUINOLINES MERCK PATENT GMBH (DE) 2005-09-07 EP disclosed
US-20040077657-A1 Piperazinylcarbonylquinolines and -isoquinolines MERCK PATENT GMBH (DE) 2004-04-22 US disclosed
EP-1366039-A1 PIPERAZINYLCARBONYLQUINOLINES AND -ISOQUINOLINES MERCK PATENT GmbH (DE) 2003-12-03 EP disclosed
WO-2002057256-A1 PIPERAZINYLCARBONYLQUINOLINES AND -ISOQUINOLINES MERCK PATENT GMBH (DE) 2002-07-25 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040077657-A1 Piperazinylcarbonylquinolines and -isoquinolines TPH2, HTR2C, HTR1A GRIN2B 24/4885PRKAA2 1895/4885MEN1 1677/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.